Reconciliations to the most direct comparable GAAP financial measures can be found in today's earnings press release, which is available in the investor relations section of our website. Revenue from continuing operations was $13 million, an increase of 14% over the prior year period. Growth was driven by strong device sales, with our mass spec devices again this quarter accounting for roughly 60% of revenue and our FTR products making up the other 40%. Our adjusted EBITDA loss was $3.9 million for the quarter, an improvement of more than 45% year-over-year compared to our previously disclosed adjusted EBITDA for Q2 2024 prior to our transformation.

We are advancing with urgency and discipline towards the 908 Devices 2.0 vision outlined earlier this year, positioning the company for sustained growth and impact. Our first focus is to increase adoption of our devices to address global threats to public health and safety. We delivered another strong quarter in Q2, placing 164 devices, including a record number of XplorlR units. Our results in the first half and our pipeline give us confidence in meeting our full-year targets.

In Q2, the majority of XplorlR orders were funded through this Firefighters Assistance Grant. Combined, these grant funding levels exceed $1.7 billion, representing an approximate 11% increase from 2024 levels. legislative outcomes will institutionalize demand, support our addressable market, and clarify a growth path across our core customer segments for 2026 and beyond. In response to mounting global threats, allied nations agreed at the NATO summit in June to significantly increase defense spending, committing to invest 5% of GDP annually by 2035.

What went well
  • Revenue from continuing operations was $13.0 million, up 14% year over year and ahead of internal expectations, driven by strong handheld device sales (mass spec ~60% of revenue, FTIR ~40%).
  • Record XplorIR placements: 45 of the 164 devices shipped were XplorIR units, the product's highest quarter, with the majority funded through the federal Assistance to Firefighters Grant.
  • Adjusted EBITDA loss narrowed to $3.9 million, an improvement of more than 45% versus pre-transformation Q2 2024 and down 15% sequentially, keeping the company on track for its Q4 adjusted-EBITDA-positive goal.
  • Recurring revenue grew 28% to $4.7 million (36% of total revenue), led by service revenue and accessories such as the XplorIR quantification module and MX908 Aero modules.
  • Launched VipIR, a three-in-one FTIR + Raman handheld chemical analyzer, in July with positive early feedback from multiple customs agencies.
  • Acquired the assets of KAF Manufacturing for $2.75 million to insource precision machining (about $5 million of prior annual external spend) and signed a three-year, $6.6 million OEM optical-component supply agreement ($750,000 upfront), de-risking the $2 million+ OEM revenue goal.
  • Completed major structural cost actions: consolidated MX908 manufacturing into Danbury, Connecticut, relocated the corporate office from Boston to Burlington, Massachusetts, cut facility square footage 44% and headcount 39% year over year.
  • Ended the quarter with $118.6 million in cash, cash equivalents and marketable securities and no debt.
What went wrong
  • GAAP gross margin fell to 49% from 54%, driven by RedWave acquisition intangible amortization, restructuring charges and higher warranty costs from a growing installed base; adjusted gross margin declined about 220 basis points to 56%.
  • Net loss from continuing operations widened to $12.9 million from $7.6 million, driven mainly by a $6.8 million non-cash contingent-consideration fair-value charge and about $1 million of facility shutdown and restructuring charges.
  • Total operating expenses rose to $21.5 million from $14.7 million a year earlier.
  • The company consumed approximately $5.7 million of cash during the quarter.
  • No meaningful revenue was assumed from the U.S. DoD AVCAD program in 2025, with full-rate production pushed to 2026.
  • Second-half revenue was now expected to skew toward Q4 (roughly a 45%/55% split between Q3 and Q4) on the timing of a few large orders.

Guidance Changes

MetricPeriodCurrent guidance
FY2025 revenue from continuing operationsFY2025$54-$56 million, representing 13%-17% growth over FY2024
FY2025 handheld product & service revenueFY2025grow 17%-21% year over year, equating to $52-$54 million
FY2025 OEM & funded partnerships (incl. contract revenue)FY2025~$2 million
FY2025 adjusted gross marginFY2025mid-to-high 50% range
Q4 revenue / adjusted EBITDAQ4 FY2025~$17 million revenue supporting a target of adjusted-EBITDA positive in Q4
2026 revenue growthFY2026expected to accelerate above 20%

Performance Breakdown

MetricYoYNote
Total revenue (continuing ops) +14% to $13.0 million Strong handheld device sales, led by record XplorIR placements
Handheld product & service revenue +13% to $12.5 million Higher device placements (164 vs. 143 units)
Recurring revenue +28% to $4.7 million (36% of revenue) Service revenue and accessories (XplorIR quant module, MX908 Aero)
Adjusted EBITDA loss of $3.9 million (>45% better vs. pre-transformation Q2 2024) Cost discipline and structural cost actions
Gross margin 49%, down from 54% RedWave intangible amortization, restructuring and higher warranty costs
Installed base 3,336 devices 164 devices shipped in the quarter

Earnings Call Themes & Trends

TopicPrevious mentionCurrent periodTrend
908 Devices 2.0 transformationStrategy outlined earlier in 2025Executing three focus areas - device adoption, next-gen portfolio, and financial discipline
Path to profitabilityTargeting adjusted-EBITDA positive by Q4 2025Q2 adjusted EBITDA loss down 15% sequentially; Q4 target reiterated
Legislative and funding tailwindsEmerging federal supportOne Big Beautiful Bill and appropriations provide $1.7B+ in grant funding (~+11% vs 2024); DHS +7%; NATO 5%-of-GDP commitment
Next-gen portfolioVipIR in developmentVipIR launched in July; next-gen MX908 on track for 2026
Vertical integration and OEMReliance on external machiningKAF asset acquisition insources precision machining and a $6.6M OEM supply deal supports the $2M+ OEM revenue goal

Q&A Summary

Are the federal-funding and international-security tailwinds already in the numbers or upside?
Knopp said it is more of a forward tailwind than in-quarter benefit; the U.S. is on a full-year continuing resolution, and the grant programs historically fund the company's core programs, setting up 2026 and beyond.
On crossing over to adjusted-EBITDA positive as you exit the year, can you stay there?
Griffith reiterated the Q4 target and a path to it, noting the business is seasonally cash-consuming in the first half, so results can move around on volume and timing.
What is the early uptake and contribution from the newly launched VipIR?
Knopp said VipIR is a three-in-one handheld built on the RedWave platform with strong early feedback from multiple customs organizations; Griffith framed it as mainly a 2026 revenue-inflection story with some potential second-half upside.
How is the 2026 20%+ growth split between run-rate and upside?
Knopp pointed to three catalysts - equipment modernization, new products and government programs; Griffith noted U.S. state and local was a bit over $12 million of first-half revenue as a steady run-rate driver.
How should we phase the AVCAD opportunity?
Griffith said AVCAD can be roughly $10 million per year or greater, with the full-rate production award timing still being worked through and a ramp expected in 2026.
Will new products including MX908 2.0 be built in Danbury, and does it need more CapEx?
Knopp confirmed manufacturing is consolidated in Danbury for leverage; Griffith said incremental capital for the next-gen MX908 is minimal, essentially tooling and setup.

More on 908 Devices Inc.

Reported 2025-08-05 · figures from the 908 Devices Inc. Q2 2025 earnings call.

See how VectorShift works for your firm

Request Demo